Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Alterity Therapeutics Ltd

ATHE
Current price
4.2 USD -0.05 USD (-1.18%)
Last closed 0.004 AUD
Sector Healthcare
Industry Biotechnology
Exchange AU
Capitalization 9 902 962 AUD
Yield for 12 month -60.00 %
Week
Month
Year
ATHE
21.11.2021 - 28.11.2021

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that is in Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy advance; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia. Address: American Century Mutual Funds, Inc.

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

+3 973 865 AUD

Last Year

+2 537 AUD

Current Quarter

+776 489 AUD

Last Quarter

+776 489 AUD

Current Year

+3 684 611 AUD

Last Year

Current Quarter

+713 054 AUD

Last Quarter

+713 054 AUD

Key Figures ATHE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -14 812 743 AUD
Operating Margin TTM -408.15 %
PE Ratio
Return On Assets TTM -26.64 %
PEG Ratio
Return On Equity TTM -47.38 %
Wall Street Target Price
Revenue TTM 3 973 866 AUD
Book Value 0.0091 AUD
Revenue Per Share TTM 0.002 AUD
Dividend Share
Quarterly Revenue Growth YOY -44.6 %
Dividend Yield
Gross Profit TTM 3 684 611 AUD
Earnings Share
Diluted Eps TTM
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ATHE

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ATHE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 5.02 %
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ATHE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 164.749
Price Sales TTM 4.2279
Enterprise Value EBITDA 0.7041
Price Book MRQ 0.6786

Financials ATHE

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ATHE

For 52 weeks

0.003 AUD 0.011 AUD
50 Day MA 0.0068 AUD
Shares Short Prior Month
200 Day MA 0.0072 AUD
Short Ratio
Shares Short
Short Percent